Pharmacists in Chelsea, Massachusetts


14 Pharmacists found in Chelsea
male pharmacist

Abdalla Sheikh Bana


Pharmacist
324 Broadway, Chelsea, MA 02150
617-889-1529    

male pharmacist

Brandon Appelt


Pharmacist
1010 Broadway, Chelsea, MA 02150
617-884-0917    

female pharmacist

Dr. Carolkim Huynh, PHARMD


Pharmacist
1010 Broadway, Chelsea, MA 02150
617-884-0917    



female pharmacist

Dr. Diana Lai-tran, RPH


Pharmacist
1010 Revere Beach Pkwy, Chelsea, MA 02150
617-884-1095    

female pharmacist

Miss Hang T Nguyen, PHARMD


Pharmacist
1010 Broadway, Chelsea, MA 02150
617-884-0917    

male pharmacist

Jay Bornstein, PHARMD


Pharmacist
100 Summit Ave, Chelsea, MA 02150
617-887-7192    

female pharmacist

Lauren Ashlea Flood, PHARMD, RPH


Pharmacist
1010 Broadway, Chelsea, MA 02150
617-884-0917    

male pharmacist

Matthew Machado


Pharmacist - Pharmacotherapy
1010 Broadway, Chelsea, MA 02150
617-887-9908    

female pharmacist

Muna Mohamed


Pharmacist
1010 Revere Beach Pkwy, Chelsea, MA 02150
617-884-1095    

female pharmacist

Tania Sarkissian


Pharmacist
447 Broadway, Chelsea, MA 02150
617-884-3524    

male pharmacist

Dr. Trevor Hogan, PHARMD


Pharmacist
324 Broadway, Chelsea, MA 02150
617-889-1529     617-889-1753

female pharmacist

Yuliya Malinkovich, PHARMD


Pharmacist
447 Broadway, Chelsea, MA 02150
617-884-3524     617-889-3395

female pharmacist

Yvonne Yau


Pharmacist
1010 Broadway, Chelsea, MA 02150
617-884-0917     617-884-8392

female pharmacist

Zahraa Saraf Ahmed, PHARMD, RPH


Pharmacist
301 Broadway Ste P, Chelsea, MA 02150
253-218-0830    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.